Literature DB >> 8684768

Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.

J K Wolf1, C Levenback, A Malpica, M Morris, T Burke, M F Mitchell.   

Abstract

OBJECTIVE: To evaluate the treatment and outcome of patients with adenocarcinoma in situ of the cervix, with special emphasis on cone biopsy margins.
METHODS: Sixty-one women with adenocarcinoma in situ of the cervix treated between April 1984 and December 1993 were identified. Medical records and histologic material were reviewed. Mixed lesions with both adenocarcinoma in situ and squamous cervical intraepithelial neoplasia (CIN) were included.
RESULTS: The mean age of the patients was 35.9 years. Fifty-five of the 61 (90%) patients had cone biopsies, and 44 of these 55 (80%) subsequently had hysterectomies. Eight women (13%) had associated invasive cancer. Among 50 patients in whom the status of the margins was confirmed, 23 (46%) had positive margins and 27 (54%) had negative margins. Of 23 women with positive margins, 19 had hysterectomies and ten of the 19 (53%) had residual disease in the uterus. Of 27 patients with negative cone margins, 21 had hysterectomies, and seven of the 21 (33%) had residual disease in the uterus. Two women with negative margins who did not have hysterectomies developed recurrent disease. Fifty-five of the total series of 61 patients followed-up for a median of 57 months (range 17-132) had no evidence of disease at last follow-up.
CONCLUSION: Women with adenocarcinoma in situ of the cervix often have residual disease in the uterus, regardless of whether the margins on cone biopsy are positive or negative.

Entities:  

Mesh:

Year:  1996        PMID: 8684768     DOI: 10.1016/0029-7844(96)00083-X

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Atypical Papanicolaou smear in pregnancy.

Authors:  Thomas P Connolly; A C Evans
Journal:  Clin Med Res       Date:  2005-02

2.  Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.

Authors:  Anthony B Costales; Andrea M Milbourne; Helen E Rhodes; Mark F Munsell; John J Wallbillich; Jubilee Brown; Michael Frumovitz; Lois M Ramondetta; Kathleen M Schmeler
Journal:  Gynecol Oncol       Date:  2013-03-28       Impact factor: 5.482

3.  Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix.

Authors:  Anthony B Costales; Patricia J Eifel; Michael T Deavers; Michael Frumovitz; Kathleen M Schmeler
Journal:  Gynecol Oncol Case Rep       Date:  2012-05-09

Review 4.  Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.

Authors:  Yanming Jiang; Changxian Chen; Li Li
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 5.  Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.

Authors:  Deanna Teoh; Fernanda Musa; Ritu Salani; Warner Huh; Edward Jimenez
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

6.  Oncologic and obstetric outcomes after conization for adenocarcinoma in situ or stage IA1 cervical cancer.

Authors:  Xiaoyu Wang; Yalan Bi; Huanwen Wu; Ming Wu; Lei Li
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.